Skip to main content
. 2008 Apr 4;6:37. doi: 10.1186/1477-7819-6-37

Figure 3.

Figure 3

Follow up CT-Scan. Follow up CT scan after 6 months of treatment with imatinib mesylate, showing considerable regression of tumor.